STAT3 is constitutively activated in numerous cancer cell lines and in many solid and hematological human cancers, including multiple myeloma, several lymphomas and leukemias, breast cancer, prostate cancer, ovarian carcinoma, melanoma, renal carcinoma, and colorectal carcinoma [11,12]. This evidence concerns the gene STAT3 and melanoma.